Construction of miR-331-3p overexpression vector and its effect on cell proliferation

CHEN Tao1,2 MA Lixia1,2 CUI Jingxiang1,3 GENG Jinhong1,2 ZENG Yongqing1,2 CHEN Wei1,2

(1.College of Animal Science and Technology, Shandong Agricultural University, Tai’an, Shandong, China 271018)
(2.Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, Tai’an, Shandong, China 271018)
(3.Weifang University of Science and Technology, Weifang, Shandong, China 262700)

【Abstract】To investigate the effect of miR-331-3p on the proliferation of porcine renal epithelial cells (PK15) and its mechanism, the pcDNA 3.1 (+) overexpression vector of miRNA-331-3 p (pcDNA 3.1 (+)-miR-331–3p) was constructed. PK15 cells were divided into four groups, including experimental group, experimental control group, inhibitor group, and inhibitor control group. Experimental group and experimental control group were transfected with pcDNA 3.1 (+)-miR-331-3p and pcDNA 3.1 (+), respectively. Inhibitor group and inhibitor control group were transfected with miR-331-3p inhibitor and miR-331-3p negative control (miR-331-3p NC), respectively. Above all, CCK-8 reagent was used to plot the cell proliferation curve and Propidium (PI) staining was used to detect the proportion of cell stages. Then, its expression changes were detected by quantitative real-time PCR that included the growth inhibitory protein family member 5 (ING5), cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 3 (CDK3), cyclin-dependent kinase 4 (CDK4), Cyclin B and cyclin-dependent kinase inhibitor 1 A (CDKN1A). The results showed that the expression of miRNA-331-3p was significantly increased in the experimental group. The cell proliferation curve showed that the number of cells in experimental group was significantly higher than that in experimental control group or inhibitor control group at the 48th and 72nd hour (P < 0.05). Simultaneously, inhibitor group was significantly lower than experimental control group or inhibitor control group in the number of cells at the 48th and 72nd hour (P < 0.05), but there was no significant difference between the experimental group and the control group. Compared with the experimental control group, the proportion of cells of experimental group at G0/G1 phase was decreased, the proportion of S phase and G2/M phase increased, and the inhibitor control group showed the opposite trend. Simultaneously, the expression levels of CDK2, CDK3, CDK4 , and Cyclin B genes in the experimental group were significantly increased, while ING5 and CDKN1A genes inhibiting proliferation showed a significant downward trend. These results demonstrate that the miR-331-3p overexpression vector was successfully constructed, and miR-331-3p has the ability to promote the proliferation of PK15 cells. The study lays a solid foundation for further research for its role in pig growth and development.

【Keywords】 miR-331-3p; cell proliferation; overexpression vector; PK15; pig;

【Funds】 National Natural Science Foundation of China (31401055) Shandong Provincial Natural Science Foundation (ZR2018BC046) Shandong “Double Tops” Program (SYL2017YSTD12) Shandong Provincial Modern Pig Technology and Industry System Project (SDAIT-08-02)

Download this article


    [1] Lund E, Güttinger S, Calado A, et al. Nuclear export of MicroRNA precursors. Science, 2004, 303 (5654): 95–98.

    [2] Zhuang M, Qiu XB, Cheng D, et al. MicroRNA-524promotes cell proliferation by down-regulating PTENexpression in osteosarcoma. Cancer Cell Int, 2018, 18: 114.

    [3] Pogue AI, Cui JG, Li YY, et al. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett, 2015, 476 (1): 18–22.

    [4] Chang RM, Yang H, Fang F, et al. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology, 2015, 60 (4): 1251–1263.

    [5] Guo XB, Guo L, Ji J, et al. miR-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Bioph Res Commun, 2010, 398 (1): 1-6.

    [6] Giles KM, Barker A, Zhang PM, et al. MicroRNAregulation of growth factor receptor signaling in human cancer cells//Wu W, ed. Micro RNA and Cancer. Totowa, NJ: Humana Press, 2011.

    [7] Cao YY, Chen J, Wang D, et al. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget, 2015, 6 (35): 38093–38106.

    [8] Ge YJ, Chen J. MicroRNAs in skeletal myogenesis. Cell Cycle, 2011, 10 (3): 441–448.

    [9] Walia R, Dardari R, Chaiyakul M, et al. Porcine circovirus-2 capsid protein induces cell death in PK15cells. Virology, 2014, 468–470: 126–132.

    [10] Li CH, Chen W, Hu JQ, et al. miRNA-29a targets COL3A1 to regulate the level of type III collagen in pig. Gene, 2016, 592 (1): 140–147.

    [11] Shi T, Yan XR, Qiao LY, et al. MiR-330–5p negatively regulates ovine preadipocyte differentiation by targeting branched-chain aminotransferase 2. Anim Sci J, 2018, 89 (6): 858–867.

    [12] Mi L, Chen YS, Zheng XL, et al. MicroRNA-139–5p suppresses 3T3-L1 preadipocyte differentiation through notch and IRS1/PI3K/Akt insulin signaling pathways. J Cell Biochem, 2015, 116 (7): 1195–1204.

    [13] Xu LN, Qi YL, Lv LW, et al. In vitro anti-proliferative effects of Zuojinwan on eight kinds of human cancer cell lines. Cytotechnology, 2014, 66 (1): 37–50.

    [14] Fujii T, Shimada K, Asano A, et al. MicroRNA-331–3p suppresses cervical cancer cell proliferation and E6/E7 expression by targeting NRP2. Int J Mol Sci, 2016, 17 (8): 1351–1364.

    [15] Lai YJ, He S, Ma LM, et al. HOTAIR functions as a competing endogenous RNA to regulate PTENexpression by inhibiting miR-19 in cardiac hypertrophy. Mol Cell Biochem, 2017, 432 (1/2): 179–187.

    [16] Li J, Zhang YY. Research progress of miR-331-3p in malignant tumors. Prac Oncol J, 2018, 32 (2): 125–129 (in Chinese).

    [17] Ye P, Ke XP, Zang XH, et al. Up-regulated MiR-27–3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma. Biomed Pharmacother, 2018, 101: 219–227.

    [18] Tsai LH, Lees E, Faha B, et al. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene, 1993, 8 (6): 1593–1602.

    [19] Sherr CJ, Roberts JM. Inhibitors of mammalian G1cyclin-dependent kinases. Genes Dev, 1995, 9 (10): 1149–1163.

    [20] Ito M. Factors controlling cyclin B expression. Plant Mol Biol, 2000, 43 (5/6): 677–690.

    [21] Zhang YY, Xu ZN. miR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma. Oncol Lett, 2018, 15 (2): 1723–1727.

This Article


CN: 11-1998/Q

Vol 35, No. 05, Pages 892-900

May 2019


Article Outline


  • 1 Materials and methods
  • 2 Results and analysis
  • 3 Discussion
  • 4 Conclusions
  • References